WILSON TROY EDWARD
SEC insider (Form 3/4/5 filer). CIK 0001589597. Director at PUMA BIOTECHNOLOGY, INC. (PBYI) and 3 other issuers. 31 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in LOS ANGELES, CA.
Companies WILSON TROY EDWARD has filed insider reports for
- PUMA BIOTECHNOLOGY, INC. (PBYI): Director
- Kura Oncology, Inc. (KURA): Director, Officer, President and CEO
- Atrium Therapeutics, Inc. (RNA): Director
- Avidity Biosciences, Inc. (RNAM): Director
WILSON TROY EDWARD
CIK: 0001589597
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (31 total)
- Sep 14, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect5K shares at avg. $9.10$46K - Aug 24, 2026KURA
Kura Oncology, Inc.
PurchaseIndirect100K shares at avg. $12.39$1.2M - Aug 17, 2026KURA
Kura Oncology, Inc.
PurchaseIndirect100K shares at avg. $11.12$1.1M - Jun 12, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect10.8K shares at avg. $7.20$78K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares- - Mar 23, 2026KURA
Kura Oncology, Inc.
ExerciseDirect6.1K shares at avg. $6.15$38K - Feb 27, 2026RNA
Atrium Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
20K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionDirect65.1K shares- - Feb 27, 2026RNAM
Avidity Biosciences, Inc.
DispositionIndirect13.7K shares- - Jan 2, 2026KURA
Kura Oncology, Inc.
AwardDirectOption to purchase common stock
1.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 5,000 | $9.10 | $45,500 | Direct |
| Aug 24, 2026 |  KURA Kura Oncology, Inc. | Purchase | 100,000 | $12.39 | $1,239,000 | Indirect |
| Aug 17, 2026 | KURA Kura Oncology, Inc. | Purchase | 100,000 | $11.12 | $1,112,000 | Indirect |
| Jun 12, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 10,800 | $7.20 | $77,748 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | $0 | Direct |
| Mar 23, 2026 | KURA Kura Oncology, Inc. | Exercise | 6,103 | $6.15 | $37,533 | Direct |
| Feb 27, 2026 |  RNA Atrium Therapeutics, Inc. | Award Stock Option (Right to Buy) | 20,000 | - | - | Direct |
| Feb 27, 2026 |  RNAM Avidity Biosciences, Inc. | Disposition | 65,091 | - | $0 | Direct |
| Feb 27, 2026 | RNAM Avidity Biosciences, Inc. | Disposition | 13,711 | - | $0 | Indirect |
| Jan 2, 2026 | KURA Kura Oncology, Inc. | Award Option to purchase common stock | 1,120,000 | - | - | Direct |
1-10 of 31 transactions